These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22057994)

  • 61. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity.
    Huber AK; Jacobson EM; Jazdzewski K; Concepcion ES; Tomer Y
    J Clin Endocrinol Metab; 2008 Mar; 93(3):1077-81. PubMed ID: 18073300
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association between methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility to Graves' ophthalmopathy.
    Lee JY; Kim NK; Cho YW; Lew H
    Mol Med Rep; 2016 Sep; 14(3):2276-82. PubMed ID: 27430300
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comprehensive analysis of cytokine gene polymorphisms defines the association of IL-12 gene with ophthalmopthy in Korean children with autoimmune thyroid disease.
    Jang JP; Cho WK; Baek IC; Choi EJ; Shin DH; Suh BK; Kim TG
    Mol Cell Endocrinol; 2016 May; 426():43-9. PubMed ID: 26850223
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association of G-174C polymorphism of the interleukin-6 gene promoter with Graves' ophthalmopathy.
    Bednarczuk T; Kuryłowicz A; Hiromatsu Y; Kiljańskic J; Telichowska A; Nauman J
    Autoimmunity; 2004 May; 37(3):223-6. PubMed ID: 15497456
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intercellular adhesion molecule 1 gene polymorphisms in Graves' disease.
    Kretowski A; Wawrusiewicz N; Mironczuk K; Mysliwiec J; Kretowska M; Kinalska I
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4945-9. PubMed ID: 14557478
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of BTG2, CYR61, ZFP36, and SCD gene polymorphisms with Graves' disease and ophthalmopathy.
    Planck T; Shahida B; Sjögren M; Groop L; Hallengren B; Lantz M
    Thyroid; 2014 Jul; 24(7):1156-61. PubMed ID: 24780075
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Foxp3 gene polymorphisms and haplotypes associate with susceptibility of Graves' disease in Chinese Han population.
    Zheng L; Wang X; Xu L; Wang N; Cai P; Liang T; Hu L
    Int Immunopharmacol; 2015 Apr; 25(2):425-31. PubMed ID: 25708657
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intercellular adhesion molecule 1 gene polymorphisms do not contribute to Graves' disease in Chinese patients.
    Wang S; Sun H; Chen HY; Zhao ZF; Yang Y; Zhao YJ; Cui B; Ning G
    Endocrine; 2007 Apr; 31(2):114-8. PubMed ID: 17873320
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves' disease.
    Xiao W; Liu Z; Lin J; Li J; Wu K; Ma Y; Gong Y; Liu Z
    Autoimmunity; 2015 Feb; 48(1):13-8. PubMed ID: 25028161
    [TBL] [Abstract][Full Text] [Related]  

  • 70. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.
    Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS
    J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Type 2 diabetic patients with Graves' disease have more frequent and severe Graves' orbitopathy.
    Le Moli R; Muscia V; Tumminia A; Frittitta L; Buscema M; Palermo F; Sciacca L; Squatrito S; Vigneri R
    Nutr Metab Cardiovasc Dis; 2015 May; 25(5):452-7. PubMed ID: 25746910
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of FoxP3 promoter polymorphisms with the risk of Graves' disease in ethnic Kashmiri population.
    Shehjar F; Afroze D; Misgar RA; Malik SA; Laway BA
    Gene; 2018 Sep; 672():88-92. PubMed ID: 29890310
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic Associations of Interleukin-related Genes with Graves' Ophthalmopathy: a Systematic Review and Meta-analysis.
    Wong KH; Rong SS; Chong KK; Young AL; Pang CP; Chen LJ
    Sci Rep; 2015 Nov; 5():16672. PubMed ID: 26578206
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Polymorphisms of ST2-IL18R1-IL18RAP gene cluster: a new risk for autoimmune thyroid diseases.
    Wang X; Zhu YF; Li DM; Qin Q; Wang Q; Muhali FS; Jiang WJ; Zhang JA
    Int J Immunogenet; 2016 Feb; 43(1):18-24. PubMed ID: 26566691
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An Intronic HCP5 Variant Is Associated With Age of Onset and Susceptibility to Graves Disease in UK and Polish Cohorts.
    Lane LC; Kuś A; Bednarczuk T; Bossowski A; Daroszewski J; Jurecka-Lubieniecka B; Cordell HJ; Pearce SHS; Cheetham T; Mitchell AL
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3277-84. PubMed ID: 32501499
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of IL-29 in Euthyroid Patients with Graves' Orbitopathy: A Preliminary Study.
    Falkowski B; Szczepanek-Parulska E; Sawicka-Gutaj N; Krygier A; Ruchala M
    Mediators Inflamm; 2020; 2020():4748612. PubMed ID: 32694926
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association between age at diagnosis of Graves' disease and variants in genes involved in immune response.
    Jurecka-Lubieniecka B; Ploski R; Kula D; Krol A; Bednarczuk T; Kolosza Z; Tukiendorf A; Szpak-Ulczok S; Stanjek-Cichoracka A; Polanska J; Jarzab B
    PLoS One; 2013; 8(3):e59349. PubMed ID: 23544060
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association between polymorphisms in the TSHR gene and Graves' orbitopathy.
    Jurecka-Lubieniecka B; Ploski R; Kula D; Szymanski K; Bednarczuk T; Ambroziak U; Hasse-Lazar K; Hyla-Klekot L; Tukiendorf A; Kolosza Z; Jarzab B
    PLoS One; 2014; 9(7):e102653. PubMed ID: 25061884
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum selenium status in Graves' disease with and without orbitopathy: a case-control study.
    Khong JJ; Goldstein RF; Sanders KM; Schneider H; Pope J; Burdon KP; Craig JE; Ebeling PR
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):905-10. PubMed ID: 24372054
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Polymorphisms of interleukin 4 receptor gene and interleukin 10 gene are not associated with Graves' disease in the UK.
    Tait KF; Nithiyananthan R; Heward JM; Barnett AH; Franklyn JA; Gough SC
    Autoimmunity; 2004 May; 37(3):189-94. PubMed ID: 15497451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.